BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37487818)

  • 1. Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
    Morton JI; Carstensen B; McDonald SP; Polkinghorne KR; Shaw JE; Magliano DJ
    Am J Kidney Dis; 2023 Nov; 82(5):608-616. PubMed ID: 37487818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in Incidence of ESKD in People With Type 1 and Type 2 Diabetes in Australia, 2002-2013.
    Koye DN; Magliano DJ; Reid CM; Pavkov ME; Chadban SJ; McDonald SP; Polkinghorne KR; White S; Paul C; Shaw JE
    Am J Kidney Dis; 2019 Mar; 73(3):300-308. PubMed ID: 30579709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage kidney disease and rationing of kidney replacement therapy in the free state province, South Africa: a retrospective study.
    Molaoa TT; Bisiwe FB; Ndlovu KC
    BMC Nephrol; 2021 May; 22(1):174. PubMed ID: 33975539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy.
    Thurlow JS; Joshi M; Yan G; Norris KC; Agodoa LY; Yuan CM; Nee R
    Am J Nephrol; 2021; 52(2):98-107. PubMed ID: 33752206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Association Between Age of Onset of Type 2 Diabetes and the Long-term Risk of End-Stage Kidney Disease: A National Registry Study.
    Morton JI; Liew D; McDonald SP; Shaw JE; Magliano DJ
    Diabetes Care; 2020 Aug; 43(8):1788-1795. PubMed ID: 32540924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
    De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
    BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.
    Harding JL; Morton JI; Shaw JE; Patzer RE; McDonald SP; Magliano DJ
    Nephrol Dial Transplant; 2022 Sep; 37(10):2004-2013. PubMed ID: 34724066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry.
    Derner O; Kramer A; Hruskova Z; Arici M; Collart F; Finne P; Fuentes Sánchez L; Harambat J; Hemmelder MH; Hommel K; Kerschbaum J; De Meester J; Palsson R; Segelmark M; Skrunes R; Traynor JP; Zurriaga O; Massy ZA; Jager KJ; Stel VS; Tesar V
    Am J Kidney Dis; 2022 May; 79(5):635-645. PubMed ID: 34752912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
    de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
    Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cause of death for people with end-stage kidney disease withdrawing from treatment in Australia and New Zealand.
    Khou V; De La Mata NL; Morton RL; Kelly PJ; Webster AC
    Nephrol Dial Transplant; 2021 Jul; 36(8):1527-1537. PubMed ID: 32750144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Rates of Surgery and Postoperative Mortality Among Patients Receiving Chronic Kidney Replacement Therapy: A Population-based Cohort Study.
    Palamuthusingam D; Hawley CM; Pascoe EM; Johnson DW; Sivalingam P; McDonald S; Boudville N; Jose MD; Talaulikar G; Fahim M
    Ann Surg; 2022 Dec; 276(6):1002-1010. PubMed ID: 36052682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study.
    Wu H; Lau ESH; Yang A; Szeto CC; Ma RCW; Kong APS; Chow E; So WY; Chan JCN; Luk AOY
    Lancet Reg Health West Pac; 2021 Jun; 11():100165. PubMed ID: 34327367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry.
    ElHafeez SA; Kramer A; Arici M; Arnol M; Åsberg A; Bell S; Belliere J; Corte CD; Fresnedo GF; Hemmelder M; Heylen L; Hommel K; Kerschbaum J; Naumović R; Nitsch D; Santamaria R; Finne P; Palsson R; Pippias M; Resic H; Rosenberg M; de Pablos CS; Segelmark M; Sørensen SS; Soler MJ; Vidal E; Jager KJ; Ortiz A; Stel VS
    Nephrol Dial Transplant; 2024 Feb; ():. PubMed ID: 38327216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing fertility rates in Australian women receiving kidney replacement therapy: analysis of linked Australia and New Zealand Dialysis and Transplant Registry and perinatal data over 22 years.
    Hewawasam E; Davies CE; Gulyani A; Li Z; Clayton PA; Sullivan E; McDonald SP; Jesudason S
    Nephrol Dial Transplant; 2022 May; 37(6):1152-1161. PubMed ID: 33848341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the total prevalence and incidence of end-stage kidney disease among Aboriginal and non-Aboriginal populations in the Northern Territory of Australia, using multiple data sources.
    Li L; Guthridge S; Li SQ; Zhao Y; Lawton P; Cass A
    BMC Nephrol; 2018 Jan; 19(1):15. PubMed ID: 29334912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing numbers and improved overall survival of patients on kidney replacement therapy over the last decade in Europe: an ERA Registry study.
    Huijben JA; Kramer A; Kerschbaum J; de Meester J; Collart F; Arévalo OLR; Helve J; Lassalle M; Palsson R; Ten Dam M; Casula A; Methven S; Ortiz A; Ferraro PM; Segelmark M; Mingo PU; Arici M; Reisæter AV; Stendahl M; Stel VS; Jager KJ
    Nephrol Dial Transplant; 2023 Mar; 38(4):1027-1040. PubMed ID: 35974693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
    Yang WL; Bose B; Zhang L; Mcstea M; Cho Y; Fahim M; Hawley CM; Pascoe EM; Johnson DW
    PLoS One; 2019; 14(8):e0221531. PubMed ID: 31442267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excess all-cause and cause-specific mortality for people with diabetes and end-stage kidney disease.
    Morton JI; Sacre JW; McDonald SP; Magliano DJ; Shaw JE
    Diabet Med; 2022 Jun; 39(6):e14775. PubMed ID: 34951712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstetric Deliveries in US Women With ESKD: 2002-2015.
    Oliverio AL; Bragg-Gresham JL; Admon LK; Wright Nunes JA; Saran R; Heung M
    Am J Kidney Dis; 2020 May; 75(5):762-771. PubMed ID: 31785826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
    Grace BS; Clayton P; McDonald SP
    Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.